Sunshine Biopharma is a pharmaceutical company operating in the pharmaceutical testing services sector, as well as, in the research, development and commercialization of drugs for the treatment of cancer and other acute and chronic indications.

Generic Drugs - Coming Soon

SBI-Anastrozole for treatment of Breast Cancer
SBI-Letrozole for treatment of Breast Cancer
SBI-Bicalutamide treatment of Prostate Cancer
SBI-Finasteride for treatment of BPH (Benign Prostatic Hyperplasia)

By prescription only.
Not available in the United States.

Press Releases

September 14, 2018
Sunshine Biopharma Announces $10 Million Equity Financing

August 16, 2018
Sunshine Biopharma Signs A Service Agreement With Utah Based Quintessential Biosciences Inc.

June 18, 2018
Sunshine Biopharma Launches Microbiology Testing Service

May 10, 2018
Sunshine Biopharma Annouces Extension Of The Term Of Its Brokered Up To $10 Million Private Placement Financing

January 4, 2018
Sunshine Biopharma Completes the Acquisition of Atlas Pharma

September 19, 2017
Sunshine Biopharma Annouces The Terms Of Its Brokered Up To $10 Million In Private Placement Financing

September 5, 2017
Sunshine Biopharma Enters Into An Investment Banking Agreement With Jitney Trade To Raise Up To $10 Million For Clinical Trials Of Adva-27a Anticancer Drug

June 26, 2017
Sunshine Biopharma Releases Results of Independent Valuation

June 19, 2017
Sunshine Biopharma Files An Application With Health Canada For A Drug Establishment License

January 11, 2017
Sunshine Biopharma Currently Reviewing Twenty Three Additional Generic Products For In-licensing